As shown in Figure 3b, treatment with orlistat, SMF, SAF, or SMF + SAF for 3 weeks after induction of obesity significantly down-regulated the mRNA levels of the FTO gene in all treatment groups (with the exception of group 7) in a dose-dependent manner when compared with the untreated group 2. Here, FTO is linked to obesity disorder.